Although BAD has not been previously implicated in skin cancers, loss or downregulation of other proapoptotic members of the BCL-2 family, i.e., BAX and PUMA, has been shown to promote the development of BCC, SCC, and cutaneous melanoma (140, 141). The gene discussed is BAX; the disease is skin cancer.